Expression and role of miR-34a in bladder cancer

Indian Journal of Biochemistry and Biophysics

Volumn 50, Issue 2, 2013, Pages 87-92

  Wang, Wei ^a   Li, Tan ^a   Han, Guang ^a   Li, Ying ^a   Shi, Li Hua ^a   Li, Hui ^a  

^a MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

Apoptosis; Bladder cancer; microRNA 34a; Pathological variables; Proliferation

Indexed keywords

CASPASE 3; MICRORNA; MIRN34 MICRORNA, HUMAN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TUMOR MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; BIOSYNTHESIS; BLADDER TUMOR; CELL CYCLE; CELL PROLIFERATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TIME; TUMOR CELL LINE;

ADULT; AGED; APOPTOSIS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84924341700     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ploeg M, Aben K K & Kiemeney L A (2009) World J Urol 27, 289-293
2. Parkin D M (2008) Scand J Urol Nephrol Supplementum (218), 12-20
3. Croce C M & Calin G A (2005) Cell 122, 6-7
4. Hatfield S & Ruohola-Baker H (2008) Cell Tissue Res 331, 57-66
5. Liu Y, Han Y, Zhang H, Nie L, Jiang Z, Fa P, Gui Y & Cai Z (2012) PLoS One 7, e52280
6. Majid S, Dar A A, Saini S, Shahryari V, Arora S, Zaman M S, Chang I, Yamamura S, Chiyomaru T, Fukuhara S, Tanaka Y, Deng G, Tabatabai Z L & Dahiya R (2012) PLoS One 7, e46743
7. He L, He X, Lim L P, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson A L, Linsley P S, Chen C, Lowe S W, Cleary M A & Hannon G J (2007) Nature 447, 1130-1134
8. He L, He X, Lowe S W & Hannon G J (2007) NatureRev 7, 819-822
9. Ji Q, Hao X, Meng Y, Zhang M, Desano J, Fan D & Xu L (2008) BMC Cancer 8, 266
10. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G & Hermeking H (2007) Cell Cycle 6, 1586-1593
11. Nalls D, Tang S N, Rodova M, Srivastava R K & Shankar S (2011) PLoS One 6, e24099
12. Yan D, Zhou X, Chen X, Hu D N, Dong X D, Wang J, Lu F, Tu L & Qu J (2009) Investig Ophthalmol Visual Sci 50, 1559-1565
13. Dutta KK, Zhong Y, Liu YT., Yamada T, Akatsuka S, Hu Q, Yoshihara M, Ohara H, Takehashi M, Shinohara T, Masutani H, Onuki J & Toyokuni S (2007) Cancer Sci 98, 1845-1852
14. Boominathan L (2010) PloS one 5, e10615
15. Suzuki H I., Yamagata K, Sugimoto K, Iwamoto T, Kato S & Miyazono K (2009) Nature 460, 529-533
16. Vinall R L, Ripoll A Z, Wang S, Pan C X & deVere White R W (2012) Int J Cancer 130, 2526-2538
17. Hermeking H (2007) Cancer Cell 12, 414-418
18. Hermeking H (2010) Cell Death Differentiation 17, 193-199
19. Merkel O, Asslaber D, Piñón J D, Egle A & Greil R (2010) Cell Cycle 15, 2764-2768
20. Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L, Xiang D, Desano J T, Bommer G T, Fan D, Fearon E R, Lawrence T S & Xu L (2009) PloS one 4, e6816
21. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, Korner H, Knyazev P, Diebold J & Hermeking H (2008) Cell Cycle 7, 2591-2600